Back to Trades
BIENAIME JEAN JACQUES
InsiderCIK 0001221590
Total Volume
$9.7M
14 filings
Purchases
$986.7K
14 buy txns
Sales
$203.8K
2 sell txns
Net Activity
$782.9K
net bought
Profile
- Filings
- 14
- Buy transactions
- 14
- Sell transactions
- 2
- Companies
- 4
- Active
- 2026
BIENAIME JEAN JACQUES has filed 14 SEC reports (2026), spread across 4 companies, totaling $9.7M in disclosed volume. Weighing $986.7K bought versus $203.8K sold, the history is net buying. The largest single open-market purchase on record is $492.7K in Ascendis Pharma A/S. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
14 loaded
| Sep 28 | ASND Ascendis Pharma A/S | BIENAIME JEAN JACQUES | Insider | Award | $3.9M |
| Aug 19 | KROS Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Insider | Buy | $10.3K |
| Aug 18 | ASND Ascendis Pharma A/S | BIENAIME JEAN JACQUES | Insider | Buy | $492.7K |
| Jul 17 | KROS Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Insider | Buy | $10.6K |
| Jun 17 | KROS Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Insider | Buy | $10.2K |
| Jun 12 | IMNM Immunome Inc. | BIENAIME JEAN JACQUES | Insider | Award | $179.7K |
| Jun 10 | INCY INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | $615.0K |
| Jun 9 | IMNM Immunome Inc. | BIENAIME JEAN JACQUES | Insider | Buy | $204.3K |
| Jun 5 | KROS Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Insider | Grant | $78.0K |
| Jun 1 | ASND Ascendis Pharma A/S | BIENAIME JEAN JACQUES | Insider | Buy | $111.6K |
| May 28 | INCY INCYTE CORP | BIENAIME JEAN JACQUES | Director | Exercise | $3.8M |
| May 19 | IMNM Immunome Inc. | BIENAIME JEAN JACQUES | Insider | Buy | $103.5K |
| Apr 1 | ASND Ascendis Pharma A/S | BIENAIME JEAN JACQUES | Insider | Other | $0 |
| Mar 12 | IMNM Immunome Inc. | BIENAIME JEAN JACQUES | Insider | Buy | $43.7K |
14 filings